Clinical Trials
7
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen
- First Posted Date
- 2018-12-11
- Last Posted Date
- 2021-03-17
- Lead Sponsor
- NanoCarrier Co., Ltd.
- Target Recruit Count
- 136
- Registration Number
- NCT03771820
- Locations
- 🇭🇷
0603, Osijek, Croatia
🇭🇷0601, Zagreb, Croatia
🇭🇷0602, Zagreb, Croatia
Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2020-02-28
- Lead Sponsor
- NanoCarrier Co., Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT03168061
- Locations
- 🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸University of California Los Angeles, Santa Monica, California, United States
🇺🇸Sarcoma Oncology Research Center, LLC., Santa Monica, California, United States
Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2018-02-23
- Lead Sponsor
- NanoCarrier Co., Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT03168035
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Conditions
- Carcinoma, Squamous Cell of Head and Neck
- Interventions
- First Posted Date
- 2017-04-12
- Last Posted Date
- 2019-04-29
- Lead Sponsor
- NanoCarrier Co., Ltd.
- Target Recruit Count
- 1
- Registration Number
- NCT03109158
- Locations
- 🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States
🇺🇸Winship Cancer Institute, Emory University, Atlanta, Georgia, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- NanoCarrier Co., Ltd.
- Target Recruit Count
- 119
- Registration Number
- NCT02240238
- Locations
- 🇺🇸
California Cancer Associates for Research and Excellence, Encinitas, California, United States
🇺🇸UC San Diego Moores Cancer Center, La Jolla, California, United States
🇺🇸Pacific Hematology Oncology Associates, San Francisco, California, United States
- Prev
- 1
- 2
- Next